TG THERAPEUTICS, INC. (TGTX) reporting calendar
TG THERAPEUTICS, INC. files periodic reports with the SEC as TGTX on Nasdaq. Atlas tracks 77 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 26 Jul 2026 – 21 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 77
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open TGTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001437749-26-015246 |
| 10-K | 31 Dec 2025 | 27 Feb 2026 | 58 days | 0001437749-26-006133 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001437749-25-033363 |
| 10-Q | 30 Jun 2025 | 8 Aug 2025 | 39 days | 0001437749-25-025745 |
| 10-Q | 31 Mar 2025 | 9 May 2025 | 39 days | 0001437749-25-015804 |
| 10-K | 31 Dec 2024 | 3 Mar 2025 | 62 days | 0001437749-25-005908 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0001437749-24-033948 |
| 10-Q | 30 Jun 2024 | 9 Aug 2024 | 40 days | 0001437749-24-025853 |
| 10-Q | 31 Mar 2024 | 6 May 2024 | 36 days | 0001437749-24-014849 |
| 10-K | 31 Dec 2023 | 29 Feb 2024 | 60 days | 0001437749-24-006144 |
| 10-Q | 30 Sep 2023 | 6 Nov 2023 | 37 days | 0001437749-23-030412 |
| 10-Q | 30 Jun 2023 | 4 Aug 2023 | 35 days | 0001558370-23-013429 |
| 10-Q | 31 Mar 2023 | 8 May 2023 | 38 days | 0001558370-23-008385 |
| 10-K | 31 Dec 2022 | 1 Mar 2023 | 60 days | 0001558370-23-002610 |
| 10-Q | 30 Sep 2022 | 9 Nov 2022 | 40 days | 0001558370-22-017180 |
| 10-Q | 30 Jun 2022 | 9 Aug 2022 | 40 days | 0001558370-22-012854 |
| 10-Q | 31 Mar 2022 | 10 May 2022 | 40 days | 0001558370-22-008130 |
| 10-K | 31 Dec 2021 | 1 Mar 2022 | 60 days | 0001558370-22-002617 |
| 10-Q | 30 Sep 2021 | 8 Nov 2021 | 39 days | 0001558370-21-015039 |
| 10-Q | 30 Jun 2021 | 6 Aug 2021 | 37 days | 0001558370-21-010837 |
| 10-Q | 31 Mar 2021 | 10 May 2021 | 40 days | 0001558370-21-006712 |
| 10-K | 31 Dec 2020 | 1 Mar 2021 | 60 days | 0001558370-21-002149 |
| 10-Q | 30 Sep 2020 | 9 Nov 2020 | 40 days | 0001558370-20-013410 |
| 10-Q | 30 Jun 2020 | 10 Aug 2020 | 41 days | 0001558370-20-010225 |
| 10-Q | 31 Mar 2020 | 11 May 2020 | 41 days | 0001558370-20-006304 |
| 10-K | 31 Dec 2019 | 2 Mar 2020 | 62 days | 0001558370-20-001897 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001654954-19-012751 |
| 10-Q | 30 Jun 2019 | 9 Aug 2019 | 40 days | 0001654954-19-009176 |
| 10-Q | 10 May 2019 | 10 May 2019 | 0 days | 0001654954-19-005680 |
| 10-K | 31 Dec 2018 | 1 Mar 2019 | 60 days | 0001654954-19-002189 |
| 10-Q | 30 Sep 2018 | 9 Nov 2018 | 40 days | 0001654954-18-012303 |
| 10-Q | 30 Jun 2018 | 9 Aug 2018 | 40 days | 0001654954-18-008750 |
| 10-Q | 31 Mar 2018 | 10 May 2018 | 40 days | 0001654954-18-005046 |
| 10-K | 31 Dec 2017 | 15 Mar 2018 | 74 days | 0001654954-18-002638 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001654954-17-010322 |
| 10-Q | 30 Jun 2017 | 9 Aug 2017 | 40 days | 0001654954-17-007129 |
| 10-Q | 31 Mar 2017 | 10 May 2017 | 40 days | 0001654954-17-004345 |
| 10-K | 31 Dec 2016 | 16 Mar 2017 | 75 days | 0001654954-17-002050 |
| 10-Q | 30 Sep 2016 | 9 Nov 2016 | 40 days | 0001654954-16-003692 |
| 10-Q | 30 Jun 2016 | 9 Aug 2016 | 40 days | 0001654954-16-001302 |
Source: SEC EDGAR company submissions for CIK 0001001316. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.